Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

430
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
430
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.3K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.3K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

124
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
124
Glaucoma: Overview01:25

Glaucoma: Overview

815
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
815
Trachea01:22

Trachea

2.8K
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
2.8K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

746
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
746

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A snapshot of selected neglected tropical disease research using the World Health Organization International Clinical Trials Registry Platform database, 1999-2023.

PLoS neglected tropical diseases·2026
Same author

Double-dose azithromycin mass drug administration, facial cleanliness, and fly control measures for trachoma control in Oromia, Ethiopia (Stronger SAFE): a cluster-randomised controlled trial.

The Lancet. Infectious diseases·2026
Same author

A Randomised Trial of Three Face-Washing Methods for the Removal of Chlamydia trachomatis From the Faces of Children With Severe Active Trachoma.

Tropical medicine & international health : TM & IH·2026
Same author

Surveys to substantiate elimination of trachoma as a public health problem in the Republic of the Union of Myanmar.

International health·2025
Same author

Population-based concordance of <i>Chlamydia trachomatis</i> genotypes between ocular and urogenital samples in Nauru.

Microbiology spectrum·2025
Same author

Discrepancy between active trachoma and tests of chlamydial infection in Alto Amazonas, Peru.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Sep 22, 2025

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.1K

Trachoma.

Anthony W Solomon1, Matthew J Burton2,3, Emily W Gower4,5

  • 1Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland. solomona@who.int.

Nature Reviews. Disease Primers
|May 26, 2022
PubMed
Summary
This summary is machine-generated.

Trachoma, a neglected tropical disease caused by Chlamydia trachomatis, can lead to blindness. The SAFE strategy, combining surgery, antibiotic mass drug administration, facial cleanliness, and environmental improvement, is successfully preventing trachomatous blindness.

More Related Videos

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

864
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.0K

Related Experiment Videos

Last Updated: Sep 22, 2025

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.1K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

864
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.0K

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Background:

  • Trachoma is a neglected tropical disease caused by Chlamydia trachomatis, leading to irreversible blindness in millions worldwide.
  • It involves two chronic processes: recurrent infection in children and cicatricial disease causing trichiasis later in life.
  • Blindness can occur years after infection transmission ceases, necessitating distinct public health interventions.

Purpose of the Study:

  • To highlight the pathophysiology of trachoma and its distinct disease processes.
  • To emphasize the need for targeted interventions to prevent trachomatous blindness.
  • To discuss the effectiveness of the SAFE strategy in controlling trachoma.

Main Methods:

  • Review of trachoma's linked infectious and cicatricial disease processes.
  • Analysis of public health interventions including surgery and mass drug administration.
  • Evaluation of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement).

Main Results:

  • Trachoma affects the poorest communities, with 1.8 million people blind in June 2021.
  • Over 150 infection episodes are typically required to cause trichiasis and blindness.
  • The SAFE strategy is demonstrating considerable success in reducing infection prevalence and transmission.

Conclusions:

  • Distinct clinical and public health responses are required for the infectious and cicatricial phases of trachoma.
  • The SAFE strategy is an effective approach to combatting trachoma and preventing blindness.
  • Continued efforts are crucial to eliminate trachoma as a public health problem by 2030.